{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:44:24Z","timestamp":1762875864894},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.arteri.2016.11.002","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T00:47:43Z","timestamp":1491439663000},"page":"129-140","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hipercolesterolemia familiar en la infancia y la adolescencia: una realidad oculta"],"prefix":"10.1016","volume":"29","author":[{"given":"N\u00faria","family":"Plana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e8lia","family":"Rodr\u00edguez-Borjabad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiana","family":"Ibarretxe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Llu\u00eds","family":"Masana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2016.11.002_bib0305","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/eurheartj\/ehs010","article-title":"Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemia","volume":"33","author":"Motazacker","year":"2012","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2016.11.002_bib0310","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: Gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2016.11.002_bib0315","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/eurheartj\/ehu058","article-title":"Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: Prevalence, genotype-phenotype relationship, and clinical outcome","volume":"36","author":"Sjouke","year":"2015","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2016.11.002_bib0320","unstructured":"Zamora A, Ramos R, Comas-Cuf\u00ed M, Vila A, Plana N, Masana L. Aproximaci\u00f3n a la epidemiolog\u00eda de la hipercolesterolemia familiar en base a la evidencia en la pr\u00e1ctica cl\u00ednica real. Granada: Sociedad Espa\u00f1ola de Arteriosclerosis; 2016."},{"key":"10.1016\/j.arteri.2016.11.002_bib0325","unstructured":"S\u00e1nchez RM. Hipercolesterolemia familiar homozigota en el registro de dislipemias de la SEA. Granada: Sociedad Espa\u00f1ola de Arteriosclerosis; 2016."},{"key":"10.1016\/j.arteri.2016.11.002_bib0330","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: Guidance for clinicians to prevent coronary heart disease: Consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2016.11.002_bib0335","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/archdischild-2011-300081","article-title":"Paediatric screening for hypercholesterolaemia in Europe","volume":"97","author":"Kusters","year":"2012","journal-title":"Arch Dis Child."},{"key":"10.1016\/j.arteri.2016.11.002_bib0340","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2003.11.010","article-title":"Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia","volume":"173","author":"Civeira","year":"2004","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2016.11.002_bib0345","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial hypercholesterolemia in the Danish general population: Prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.arteri.2016.11.002_bib0350","article-title":"The UK Paediatric Familial Hypercholesterolaemia Register: Preliminary data","author":"Ramaswami","year":"2016","journal-title":"Arch Dis Child."},{"key":"10.1016\/j.arteri.2016.11.002_bib0355","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.arteri.2013.07.005","article-title":"Expert consensus on the detection and clinical management of familial hypercholesterolemia","volume":"25","author":"Masana","year":"2013","journal-title":"Clin Investig Arterioscler."},{"issue":"3 Suppl","key":"10.1016\/j.arteri.2016.11.002_bib0360","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.jacl.2011.03.453","article-title":"Pediatric aspects of familial hypercholesterolemias: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Daniels","year":"2011","journal-title":"J Clin Lipidol."},{"key":"10.1016\/j.arteri.2016.11.002_bib0365","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.atherosclerosis.2011.06.016","article-title":"Management of familial hypercholesterolemia in children and young adults: Consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutricionists, gastroenterologists, general practitioners and a patient organization","volume":"218","author":"Descamps","year":"2011","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2016.11.002_bib0370","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jpeds.2015.11.018","article-title":"Changes in fasting lipids during puberty","volume":"170","author":"Eissa","year":"2016","journal-title":"J Pediatr."},{"key":"10.1016\/j.arteri.2016.11.002_bib0375","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jpeds.2015.11.019","article-title":"Prevalence of familial hypercholesterolemia in adolescents: Potential value of universal screening?","volume":"170","author":"Pang","year":"2016","journal-title":"J Pediatr."},{"key":"10.1016\/j.arteri.2016.11.002_bib0380","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/bmj.39395.370278.80","article-title":"Child-parent screening for familial hypercholesterolemia: Screening needs a fresh approach","volume":"335","author":"Wald","year":"2007","journal-title":"BMJ."},{"key":"10.1016\/j.arteri.2016.11.002_bib0385","first-page":"525","article-title":"National Cholesterol Education Program: Report of the Expert Panel of Blood Cholesterol Levels in Children and Adolescents","volume":"89","year":"1992","journal-title":"Pediatrics."},{"key":"10.1016\/j.arteri.2016.11.002_bib0390","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1161\/01.CIR.0000061521.15730.6E","article-title":"American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood","volume":"107","author":"Kavey","year":"2003","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2016.11.002_bib0395","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1542\/peds.2006-1801","article-title":"Screening and treatment for lipid disorders in children and adolescents: Systematic evidence review for the US Preventive Services Task Force","volume":"120","author":"Haney","year":"2007","journal-title":"Pediatrics."},{"key":"10.1016\/j.arteri.2016.11.002_bib0400","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1586\/14779072.2013.814851","article-title":"Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia","volume":"11","author":"Langslet","year":"2013","journal-title":"Expert Rev Cardiovasc Ther."},{"key":"10.1016\/j.arteri.2016.11.002_bib0405","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.atherosclerosis.2015.07.020","article-title":"Cascade screening of familial hypercholesterolemia must go on","volume":"242","author":"Galema-Boers","year":"2015","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2016.11.002_bib0410","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacc.2016.01.008","article-title":"Attainment of LDL-cholesterol treatment goals in patients with familial hypercholesterolemia: 5-year SAFEHEART registry follow-up","volume":"67","author":"Perez de Isla","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2016.11.002_bib0415","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0300-8932(09)70021-1","article-title":"Cost-effectiveness analysis of a genetic screening program in the close relatives of Spanish patients with familial hypercholesterolemia","volume":"62","author":"Oliva","year":"2009","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.arteri.2016.11.002_bib0420","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.anpedi.2009.02.005","article-title":"Hipercolesterolemia. Abordaje terap\u00e9utico","volume":"70","author":"Mor\u00e1is-L\u00f3pez","year":"2009","journal-title":"An Pediatr (Barc)."},{"key":"10.1016\/j.arteri.2016.11.002_bib0425","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.aprim.2013.12.015","article-title":"Diagn\u00f3stico y tratamiento de la hipercolesterolemia familiar en Espa\u00f1a: documento de consenso","volume":"47","author":"Mata","year":"2015","journal-title":"Aten Primaria."},{"key":"10.1016\/j.arteri.2016.11.002_bib0430","unstructured":"Argim\u00f3n J. La aportaci\u00f3n reducida de f\u00e1rmacos hipolipemiantes en Espa\u00f1a. Modelo de aplicaci\u00f3n y sus resultados. Granada: Sociedad Espa\u00f1ola de Arteriosclerosis; 2016."},{"key":"10.1016\/j.arteri.2016.11.002_bib0435","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.arteri.2015.01.002","volume":"27","author":"Ascaso","year":"2015","journal-title":"Clin Invest Arterioscler."},{"key":"10.1016\/j.arteri.2016.11.002_bib0440","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehw135","article-title":"Selection of individuals for genetic testing for familial hypercholesterolaemia: Development and external validation of a prediction model for the presence of a mutation causing familial hypercholesterolaemia","author":"Besseling","year":"2016","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2016.11.002_bib0445","article-title":"Patients with familial hypercholesterolemia who initiated statin treatment in childhood are at lower risk for CHD then their affected parents","volume":"128","author":"Braamskamps","year":"2013","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2016.11.002_bib0450","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/oby.21087","article-title":"Lifestyle and weight predictors of a healthy overweight profile over a 20-year follow-up","volume":"23","author":"Fung","year":"2015","journal-title":"Obesity (Silver Spring)."},{"key":"10.1016\/j.arteri.2016.11.002_bib0455","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1017\/S1368980015001585","article-title":"High cardiometabolic risk in healthy Chilean adolescents: Associations with anthropometric, biological and lifestyle factors","volume":"19","author":"Burrows","year":"2016","journal-title":"Public Health Nutr."},{"key":"10.1016\/j.arteri.2016.11.002_bib0460","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1651-2227.2003.tb02574.x","article-title":"Influence of dietary intervention on growth in children with hypercholesterolaemia","volume":"92","author":"S\u00e1nchez-Bayle","year":"2003","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.arteri.2016.11.002_bib0465","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00592-010-0233-1","article-title":"Primary hyperlipidemias in children: Effect of plant sterol supplementation on plasma lipids and markers of cholesterol synthesis and absorption","volume":"48","author":"Guardamagna","year":"2011","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.arteri.2016.11.002_bib0470","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.atherosclerosis.2013.11.043","article-title":"Plant sterols and plant stanol in the management of dyslipidaemia and prevention of cardiovascular disease","volume":"232","author":"Gylling","year":"2014","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2016.11.002_bib0475","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ejcn.2014.234","article-title":"Effect of a low-fat diet enriched either with rapeseed oil or sunflower oil on plasma lipoproteins in children and adolescents with familial hypercholesterolaemia. Results of a pilot study","volume":"69","author":"Negele","year":"2015","journal-title":"Eur J Clin Nutr."},{"key":"10.1016\/j.arteri.2016.11.002_bib0480","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/archpedi.152.11.1089","article-title":"Garlic extract therapy in children with hypercholesterolemia","volume":"152","author":"McCrindle","year":"1998","journal-title":"Arch Pediatr Adolesc Med."},{"key":"10.1016\/j.arteri.2016.11.002_bib0485","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ajcn\/63.1.96","article-title":"A psyllium-enriched cereal for the treatment of hypercholesterolemia in children: A controlled, blind, crossover study","volume":"63","author":"Davidson","year":"1996","journal-title":"Am J Clin Nutr."},{"key":"10.1016\/j.arteri.2016.11.002_bib0490","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.2047-6310.2013.00173.x","article-title":"Does consumption of high-fructose corn syrup beverages cause obesity in children?","volume":"8","author":"Morgan","year":"2013","journal-title":"Pediatr Obes."},{"key":"10.1016\/j.arteri.2016.11.002_bib0495","first-page":"47","article-title":"Sugar-sweetened beverage intake before 6 years of age and weight or BMI status among older children; systematic review of prospective studies","volume":"28","author":"P\u00e9rez-Morales","year":"2013","journal-title":"Nutr Hosp."},{"key":"10.1016\/j.arteri.2016.11.002_bib0500","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s00467-014-2931-3","article-title":"Salt intake in children and its consequences on blood pressure","volume":"30","author":"Lava","year":"2015","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.arteri.2016.11.002_bib0505","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0828-282X(10)70400-1","article-title":"Dose-response relationship between physical activity and dyslipidemia in youth","volume":"26","author":"LeBlanc","year":"2010","journal-title":"Can J Cardiol."},{"key":"10.1016\/j.arteri.2016.11.002_bib0510","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1590\/S0066-782X2011005000083","article-title":"Prevalence of dyslipidemia in individuals physically active during childhood, adolescence and adult age","volume":"97","author":"Fernandes","year":"2011","journal-title":"Arq Bras Cardiol."},{"key":"10.1016\/j.arteri.2016.11.002_bib0515","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jama.1996.03530340032026","article-title":"Outcomes of a field trial to improve children's dietary patterns and physical activity: The Child and Adolescent Trial for Cardiovascular Health (CATCH)","volume":"275","author":"Luepker","year":"1996","journal-title":"JAMA."},{"key":"10.1016\/j.arteri.2016.11.002_bib0520","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jpeds.2015.05.006","article-title":"Efficacy and safety of pitavastatin in children and adolescents at high future cardiovascular risk","volume":"167","author":"Braamskamp","year":"2015","journal-title":"J Pediatr."},{"key":"10.1016\/j.arteri.2016.11.002_bib0525","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/jama.2014.8892","article-title":"Ten-years follow-up after initiation of statin therapy in children with familial hypercholesterolemia","volume":"312","author":"Kusters","year":"2014","journal-title":"JAMA."},{"key":"10.1016\/j.arteri.2016.11.002_bib0530","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11886-015-0629-1","article-title":"Optimizing treatment of familial hypercholesterolemia in children and adolescents","volume":"17","author":"Luirink","year":"2015","journal-title":"Curr Cardiol Rep."},{"key":"10.1016\/j.arteri.2016.11.002_bib0535","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jpeds.2015.02.043","article-title":"Efficacy and safety of ezetimibe monotherapy in children with heterozygous familial or nonfamilial hypercholesterolemia","volume":"166","author":"Kusters","year":"2015","journal-title":"J Pediatr."},{"key":"10.1016\/j.arteri.2016.11.002_bib0540","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.anpedi.2011.11.007","article-title":"[Use of ezetimibe in the treatment of familial hypercholesterolemia in children and adolescents] Spanish","volume":"77","author":"Araujo","year":"2012","journal-title":"An Pediatr (Barc)."},{"key":"10.1016\/j.arteri.2016.11.002_bib0545","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0214-9168(11)70004-3","article-title":"Tratamiento de la hipercolesterolemia y prevenci\u00f3n de las enfermedades cardiovasculares mediante la inhibici\u00f3n de la reabsorci\u00f3n de \u00e1cidos biliares con resincolestiramina","volume":"23","author":"Pint\u00f3","year":"2011","journal-title":"Clin Invest Arterioscler."},{"key":"10.1016\/j.arteri.2016.11.002_bib0550","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.clinthera.2013.06.014","article-title":"The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients","volume":"35","author":"Davidson","year":"2013","journal-title":"Clin Ther."},{"key":"10.1016\/j.arteri.2016.11.002_bib0555","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jacl.2011.01.005","article-title":"A systematic review of bile acid sequestrant therapy in children with familial hypercholesterolemia","volume":"5","author":"Davidson","year":"2011","journal-title":"J Clin Lipidol."},{"key":"10.1016\/j.arteri.2016.11.002_bib0560","first-page":"19","article-title":"Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis","volume":"85","author":"Go","year":"2012","journal-title":"Yale J Biol Med."},{"key":"10.1016\/j.arteri.2016.11.002_bib0565","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(14)61399-4","article-title":"PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): A randomised, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2016.11.002_bib0570","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2016.11.002_bib0575","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(14)61374-X","article-title":"Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): A randomised, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2016.11.002_bib0580","article-title":"Trial assessing long-term use of PCSK9 inhibition in patients with genetic LDL disorders (TAUSSIG): Efficacy and safety in patients with homozygous familial hypercholesterolemia receiving lipid apheresis","volume":"130","author":"Bruckert","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2016.11.002_bib0585","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(12)61731-0","article-title":"Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: A single-arm,open-label, phase 3 study","volume":"381","author":"Cuchel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.arteri.2016.11.002_bib0590","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.medcli.2014.11.002","article-title":"[Homozygous familial hypercholesterolemia. First case in Spain treated with lomitapide, an inhibitor of the synthesis of lipoproteins with apolipoprotein B] Spanish","volume":"145","author":"Alonso","year":"2015","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.arteri.2016.11.002_bib0595","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jacl.2016.04.013","article-title":"Long-term mipomersen treatment is associated with a reduction in cardiovascular events in patients with familial hypercholesterolemia","volume":"10","author":"Duell","year":"2016","journal-title":"J Clin Lipidol."},{"key":"10.1016\/j.arteri.2016.11.002_bib0600","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(10)60284-X","article-title":"Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: A randomised, double-blind, placebo-controlled trial","volume":"375","author":"Raal","year":"2010","journal-title":"Lancet."}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916816301711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916816301711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T17:49:42Z","timestamp":1569001782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916816301711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0214916816301711"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2016.11.002","relation":{},"ISSN":["0214-9168"],"issn-type":[{"value":"0214-9168","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hipercolesterolemia familiar en la infancia y la adolescencia: una realidad oculta","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2016.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Sociedad Espa\u00f1ola de Arteriosclerosis. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}